(Q69392782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

title

Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

0 references

K W Rosbe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

T W Brann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

S A Holden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

B A Teicher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

E Frei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

1 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

page(s)

32-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2590999%20AND%20SRC:MED&resulttype=core&format=json

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 October 2019

cites work

1 reference

12 December 2020

Inhibition of the recovery from potentially lethal damage by lonidamine

1 reference

12 December 2020

Phase II study of lonidamine in patients with small cell carcinoma of the lung

1 reference

12 December 2020

Cell membrane changes induced by Lonidamine in human erythrocytes and T lymphocytes, and ehrlich ascites tumor cells

1 reference

12 December 2020

Effects of Lonidamine on murine and human tumor cells in vitro. A morphological and biochemical study

1 reference

12 December 2020

Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells

1 reference

12 December 2020

Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results

1 reference

12 December 2020

Radiosensitization with 5-Bromodeoxyuridine of Chinese Hamster Cells X-Irradiated during Different Phases of the Cell Cycle

1 reference

12 December 2020

Phase II study of Lonidamine in cancer patients

1 reference

12 December 2020

Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo

1 reference

12 December 2020

Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine

1 reference

12 December 2020

Synergy, additivism and antagonism in immunosuppression. A critical review

1 reference

12 December 2020

Phase II evaluation of Lonidamine in patients with advanced malignancy

1 reference

12 December 2020

Lonidamine and radiotherapy in head and neck cancers. A pilot study

1 reference

12 December 2020

Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo

1 reference

12 December 2020

Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study

1 reference

12 December 2020

Isobologram Analysis of X-Ray-BCNU Interactions in Vitro

1 reference

12 December 2020

In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.

1 reference

12 December 2020

Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells

1 reference

12 December 2020

Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients

1 reference

12 December 2020

Action of the antitumor and antispermatogenic agent lonidamine on electron transport in ehrlich ascites tumor mitochondria

1 reference

12 December 2020

Potentiation of radiation effects on two murine tumors by lonidamine

1 reference

12 December 2020